Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery-Reference-Cited by-同舟云学术

Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery

Published:2017-07-10 Issue:10 Volume:39 Page:2004-2015
ISSN:1043-3074
Container-title:Head & Neck
language:en
Short-container-title:Head & Neck

Author:

Broglie Martina A.¹^ORCID,Stoeckli Sandro J.¹,Sauter Rafael²,Pasche Philippe³,Reinhard Antoine³,de Leval Laurence⁴,Huber Gerhard F.⁵,Pezier Thomas F.⁵,Soltermann Alex⁶,Giger Roland⁷,Arnold Andreas⁷,Dettmer Matthias⁸,Arnoux Andre⁹,Müller Martin⁹,Spreitzer Stefan¹⁰,Lang Florian¹¹,Lutchmaya Mathieu¹¹,Stauffer Edouard¹²,Espeli Vittoria¹³,Martucci Francesco¹⁴,Bongiovanni Massimo⁴,Foerbs Diana¹⁵,Jochum Wolfram¹⁵

Affiliation:

1. Department of Otorhinolaryngology, Head and Neck Surgery; Kantonsspital St. Gallen; St. Gallen Switzerland

2. Clinical Trials Unit; Kantonsspital St. Gallen; St. Gallen Switzerland

3. Department of Otorhinolaryngology, Head and Neck Surgery; University Hospital of Lausanne; Lausanne Switzerland

4. Department of Pathology; University Hospital of Lausanne; Lausanne Switzerland

5. Department of Otorhinolaryngology, Head and Neck Surgery; University Hospital of Zurich; Switzerland

6. Institute of Surgical Pathology; University Hospital of Zurich; Zurich Switzerland

7. Department of Otorhinolaryngology, Head and Neck Surgery; Bern University Hospital; Inselspital Switzerland

8. Department of Pathology; Bern University Hospital; Inselspital Switzerland

9. Department of Otorhinolaryngology, Head and Neck Surgery; Kantonsspital Aarau; Switzerland

10. Department of Pathology; Kantonsspital Aarau; Switzerland

11. Department of Otorhinolaryngology, Head and Neck Surgery; Kantonsspital Fribourg; Switzerland

12. Institute of Pathology; Promed SA; Fribourg Switzerland

13. Oncology Institute of Southern Switzerland (IOSI); Bellinzona Switzerland

14. Department of Radiooncology; Oncology Institute of Southern Switzerland (IOSI); Bellinzona Switzerland

15. Institute of Pathology; Kantonsspital St. Gallen; Switzerland

Funder

Swiss Cancer League, Bern Switzerland

Clinical Trial Unit, Kantonsspital St. Gallen, Switzerland

Publisher

Wiley

Subject

Otorhinolaryngology

Reference43 articles.

1. Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?;Olthof;Rev Med Virol.,2012

2. Quality of life of oropharyngeal cancer patients with respect to treatment strategy and p16-positivity;Broglie;Laryngoscope.,2013

3. Prevalence and expression of human papillomavirus in tonsillar carcinomas, indicating a possible viral etiology;Snijders;Int J Cancer.,1992

4. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement;Holzinger;Cancer Res.,2012

5. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial;Vermorken;Ann Oncol.,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head and Neck Cancers;Basic Radiation Oncology;2022

2. SUVmax for predicting regional control in oropharyngeal cancer;European Archives of Oto-Rhino-Laryngology;2021-11-15

3. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes;American Journal of Otolaryngology;2021-05

4. Prevalence of p16 expression in oropharyngeal squamous cell carcinoma in southern Brazil;Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology;2020-12

5. The association of smoking and outcomes in HPV-positive oropharyngeal cancer: A systematic review;American Journal of Otolaryngology;2020-09